(Q38776445)

6 September 2017

1 reference

title

The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins (English)

1 reference

6 September 2017

Esterbauer H

1

1 reference

6 September 2017

Striegl G

2

1 reference

6 September 2017

Puhl H

3

1 reference

6 September 2017

Oberreither S

4

1 reference

6 September 2017

Rotheneder M

5

1 reference

6 September 2017

el-Saadani M

6

1 reference

6 September 2017

Jürgens G

7

1 reference

6 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

Annals of the New York Academy of Sciences

6 September 2017

1 reference

6 September 2017

570

1 reference

6 September 2017

254-267

1 reference

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

6 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Free radical modification of low-density lipoprotein: mechanisms and biological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

The role of altered lipoproteins in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB14925.X

10.1111/J.1749-6632.1989.TB14925.X

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference